| Treatments |
| 1Effects | ||||||
Parameters | TMR-1002 | Latin square3 | SEM4 | T | S | P | P*T | ||
T1 | T2 | T3 | |||||||
Urea, mg/dl | 33.8 | 40.6* | 39.4* | 42.5** | 2.1 | 0.42 | 0.77 | 0.09 | 0.23 |
Glucose, mg/dl | 81.76 | 88.9 | 95.4* | 80.6 | 4.8 | 0.13 | 0.53 | 0.12 | 0.80 |
NEFA5, meq/l | 150.9 | 198.9b | 253.9ab^ | 326.8a* | 39.5 | 0.06 | 0.95 | 0.00 | 0.13 |
Somatomedins (IGF-1), ng/ml | 134.8 | 170.7 | 106.9 | 130.3 | 33.5 | 0.31 | 0.60 | 0.27 | 0.46 |
Somatotrophine (GH), ng/ml | 2.92 | 1.58 | 2.76 | 3.29 | 1.16 | 0.09 | 0.47 | 0.98 | 0.22 |
Insulin, ng/ml | 0.99 | 0.80 | 0.54** | 0.68* | 0.13 | 0.33 | 0.84 | 0.15 | 0.35 |
Insulin/GH ratio | 0.50 | 2.99 | 0.76 | 2.88 | 2.25 | 0.55 | 0.33 | 0.77 | 0.46 |